报价延迟最少15分钟:2026/06/21 08:36 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.71 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.10/-1.21
|
|
企业价值
106.28M
|
| 资产负债 |
|
每股账面净值
0.41
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
33.59M
|
|
每股收益
0.41
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest fromSwitzerland, Germany, Japan, and all other countries. |
